Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited

Bafna Pharmaceuticals Limited announced the retirement of Mr. Navin Kumar as an Independent Director upon completion of his first term, effective June 22, 2026. Consequently, he will also cease to be the Chairman of the Audit Committee and the Nomination & Remuneration Committee. The company has re-constituted these committees to ensure continued compliance with regulatory requirements. This is a routine change due to the expiry of a director's term.